Protara Therapeutics, Inc. (TARA)

Protara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.5	162.8	39.59	24.13	35.72	168.6
Short-Term Investments	90.72	7.49	25.99	60.24	55.51	-
Cash & Short-Term Investments	122.22	170.29	65.58	84.37	91.23	168.6
Cash Growth	36.43%	159.67%	-22.27%	-7.52%	-45.89%	29793.26%
Other Receivables	0.89	-	0.24	0.49	0.63	-
Receivables	0.89	-	0.24	0.49	0.63	-
Prepaid Expenses	0.63	0.93	0.89	0.59	0.53	0.53
Restricted Cash	-	-	-	-	-	0.05
Other Current Assets	1.36	0.94	1.99	0.7	0.72	0.26
Total Current Assets	125.09	172.16	68.71	86.15	93.11	169.44
Property, Plant & Equipment	4.64	5.28	6.56	7.87	8.89	2.3
Long-Term Investments	23.39	-	-	17.89	39.47	-
Goodwill	-	-	-	-	29.52	29.52
Long-Term Deferred Charges	3.04	3.25	2.66	0.08	-	-
Other Long-Term Assets	0.77	0.77	1.03	1.31	1.61	1.91
Total Assets	156.93	181.45	78.95	113.29	172.6	203.16
Accounts Payable	5.3	4.43	2.43	1.59	0.95	0.91
Accrued Expenses	3.26	5.41	2.73	3.24	2.49	1.75
Current Portion of Leases	1.2	1.12	0.98	0.92	0.86	0.09
Current Income Taxes Payable	-	-	-	-	-	0.16
Total Current Liabilities	9.76	10.96	6.15	5.74	4.3	2.92
Long-Term Leases	2.75	3.36	4.48	5.47	6.38	1
Total Liabilities	12.51	14.32	10.63	11.21	10.68	3.91
Common Stock	0.04	0.04	0.01	0.01	0.01	0.01
Additional Paid-In Capital	416.16	412.08	268.73	262.72	256.13	245.99
Retained Earnings	-271.85	-244.98	-200.38	-159.96	-94.01	-46.76
Comprehensive Income & Other	0.08	0	-0.03	-0.69	-0.21	-
Shareholders' Equity	144.42	167.13	68.32	102.08	161.91	199.24
Total Liabilities & Equity	156.93	181.45	78.95	113.29	172.6	203.16
Total Debt	3.95	4.48	5.47	6.38	7.24	1.09
Net Cash (Debt)	141.66	165.81	60.11	95.87	123.46	167.51
Net Cash Growth	67.45%	175.83%	-37.30%	-22.34%	-26.30%	29600.53%
Net Cash Per Share	4.27	8.05	5.31	8.51	10.99	23.16
Filing Date Shares Outstanding	38.58	36.77	11.43	11.31	11.25	11.23
Total Common Shares Outstanding	38.58	35.04	11.36	11.27	11.24	11.21
Working Capital	115.33	161.19	62.56	80.41	88.81	166.52
Book Value Per Share	3.74	4.77	6.01	9.06	14.41	17.77
Tangible Book Value	144.42	167.13	68.32	102.08	132.4	169.73
Tangible Book Value Per Share	3.74	4.77	6.01	9.06	11.78	15.14
Machinery	-	1.5	1.51	1.42	1.12	0.66
Leasehold Improvements	-	0.55	0.55	0.55	0.22	0.2

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q